Literature DB >> 29526021

Assessing Key Stakeholders' Knowledge, Needs, and Preferences for Head and Neck Cancer Survivorship Care Plans.

Leah L Zullig1,2,3, Katherine Ramos4, Callie Berkowitz5, Julie J Miller6, Rowena J Dolor7, Bridget F Koontz8,9, S Yousuf Zafar8,10, D Hutch Allen8, Jennifer A Tenhover8, Hayden B Bosworth11,6,8,12,13.   

Abstract

Cancer survivorship care plans (SCPs) are endorsed to support quality care for cancer survivors, but uptake is slow. We assessed knowledge, needs, and preferences for SCP content and delivery from a wide variety of stakeholders. We focused SCP content for head and neck cancer as it is a disease prone to long-term side effects requiring management from multiple providers. We conducted telephone-based, qualitative interviews. We purposively sampled head and neck cancer survivors (n = 4), primary care physicians in the community (n = 5), and providers affiliated with a large academic medical center (n = 5) who treat head and neck cancer, cancer specialists (n = 6), and nurse practitioners/supportive care staff (n = 5). Interviews were recorded, transcribed, and analyzed using direct content analysis. Few participants reported personal experience with SCPs, but most supported the concept. Several key themes emerged: (1) perceived ambiguity regarding roles and responsibilities for SCPs, (2) a need to tailor the content and language based on the intended recipient, (3) documentation process should be as automated and streamlined as possible, (4) concerns about using the SCP to coordinate with outside providers, and (5) that SCPs would have added value as a "living document." We also report SCP-related issues that are unique to serving patients diagnosed with head and neck cancer. Effort is needed to tailor SCPs for different recipients and optimize their potential for successful implementation, impact on care outcomes, and sustainability. Many cancer survivors may not receive a SCP as part of routine care. Survivors could engage their health care team by requesting a SCP.

Entities:  

Keywords:  Cancer survivors; Care coordination; Care quality; Head and neck neoplasms; Qualitative; Survivorship care plan

Mesh:

Year:  2019        PMID: 29526021      PMCID: PMC8101022          DOI: 10.1007/s13187-018-1345-5

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  19 in total

1.  Three approaches to qualitative content analysis.

Authors:  Hsiu-Fang Hsieh; Sarah E Shannon
Journal:  Qual Health Res       Date:  2005-11

2.  Treatment Summaries and Survivorship Care Plans: The Approach by the Commission on Cancer to Increase Use.

Authors:  Lawrence N Shulman; Linda Ferris; Danny M Takanishi; Daniel McKellar
Journal:  J Oncol Pract       Date:  2014-11-25       Impact factor: 3.840

Review 3.  Summing it up: an integrative review of studies of cancer survivorship care plans (2006-2013).

Authors:  Deborah K Mayer; Sarah A Birken; Devon K Check; Ronald C Chen
Journal:  Cancer       Date:  2014-09-23       Impact factor: 6.860

4.  Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors.

Authors:  Dawn L Hershman; Heather Greenlee; Danielle Awad; Kevin Kalinsky; Matthew Maurer; Grace Kranwinkel; Lois Brafman; Ramona Jayasena; Wei-Yann Tsai; Alfred I Neugut; Katherine D Crew
Journal:  Breast Cancer Res Treat       Date:  2013-03-31       Impact factor: 4.872

5.  Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer.

Authors:  Eva Grunfeld; Jim A Julian; Gregory Pond; Elizabeth Maunsell; Douglas Coyle; Amy Folkes; Anil A Joy; Louise Provencher; Daniel Rayson; Dorianne E Rheaume; Geoffrey A Porter; Lawrence F Paszat; Kathleen I Pritchard; André Robidoux; Sally Smith; Jonathan Sussman; Susan Dent; Jeffrey Sisler; Jennifer Wiernikowski; Mark N Levine
Journal:  J Clin Oncol       Date:  2011-10-31       Impact factor: 44.544

6.  Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda.

Authors:  Enola Proctor; Hiie Silmere; Ramesh Raghavan; Peter Hovmand; Greg Aarons; Alicia Bunger; Richard Griffey; Melissa Hensley
Journal:  Adm Policy Ment Health       Date:  2011-03

7.  A model for the shared care of elderly patients with cancer.

Authors:  Harvey Jay Cohen
Journal:  J Am Geriatr Soc       Date:  2009-11       Impact factor: 5.562

8.  Financial toxicity, Part I: a new name for a growing problem.

Authors:  S Yousuf Zafar; Amy P Abernethy
Journal:  Oncology (Williston Park)       Date:  2013-02       Impact factor: 2.990

9.  Survivorship care plans for patients with head and neck cancer.

Authors:  Bruce H Campbell; Becky L Massey; Katherine B Myers
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-12

10.  Do survivorship care plans impact patients' evaluations of care? A randomized evaluation with gynecologic oncology patients.

Authors:  Brittany M Brothers; Andrea Easley; Ritu Salani; Barbara L Andersen
Journal:  Gynecol Oncol       Date:  2013-03-06       Impact factor: 5.482

View more
  3 in total

1.  Documentation and incidence of late effects and screening recommendations for adolescent and young adult head and neck cancer survivors treated with radiotherapy.

Authors:  Sarah Nicole Hamilton; Omair Arshad; Jaime Kwok; Eric Tran; A Fuchsia Howard; Isabel Serrano; Karen Goddard
Journal:  Support Care Cancer       Date:  2018-11-22       Impact factor: 3.603

2.  A pilot randomized controlled trial to evaluate a survivorship care planning intervention for head and neck cancer survivor-caregiver dyads.

Authors:  Katherine R Sterba; Kent Armeson; Jane Zapka; Elizabeth Garrett-Mayer; Megan L Scallion; Tiffany K Wall; Jama Olsen; Evan M Graboyes; Anthony J Alberg; Terry A Day
Journal:  J Cancer Surviv       Date:  2022-06-27       Impact factor: 4.442

3.  Healthcare practices that increase the quality of care in cancer trajectories from a general practice perspective: a scoping review.

Authors:  Anne Nicolaisen; Gitte Bruun Lauridsen; Peter Haastrup; Dorte Gilså Hansen; Dorte Ejg Jarbøl
Journal:  Scand J Prim Health Care       Date:  2022-03-07       Impact factor: 3.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.